Head to head
Deluxe vs 3M
Side-by-side on the measures that matter, with a plain-English read. Full detail: DLX · MMM
DLX
Deluxe
25.14-0.36%
1-year price shape — +47% over the period
Quant Rating C · 87/100
vs
MMM
3M
177.99-0.27%
1-year price shape — +10% over the period
Quant Rating C · 51/100
1-year performance, rebased to 100
Deluxe edges it on the scoreable measures. Deluxe has the highest Quant Rating (87); Deluxe has done best over the past year (+47%); Deluxe trades cheapest on trailing earnings.
| DLX | MMM | |
|---|---|---|
| Snapshot | ||
| Sector | Conglomerates | -- |
| Last price | 25.14 | 177.99 |
| Change today | -0.36% | -0.27% |
| 1-year return | +47.1% | +9.7% |
| Market cap | $1.15B | $91.97B |
| 52-week range | 18.41 – 30.93 | 137.44 – 196.08 |
| Valuation | ||
| P/E (TTM) | 14.62 | 26.57 |
| P/E percentile, own 5-yr range | 54th | 83rd |
| P/B | 1.61 | 22.28 |
| Dividend yield | 4.77% | 1.72% |
| Profitability & growth | ||
| EPS (TTM) | 1.80 | 6.00 |
| Net profit (TTM) | $82.63M | $3.10B |
| Revenue (TTM) | $2.13B | $25.25B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +2.5% | +1.0% |
| Gross margin | 52.0% | 39.5% |
| Operating margin | 11.6% | 20.1% |
| Net margin | 3.8% | 14.0% |
| Free cash flow (TTM) | $214.30M | $2.68B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 91.4% | 77.0% |
| Insider activity (12mo) | 38 buy / 11 sell | 24 buy / 22 sell |
| Short interest (% of float) | 8.9% | 1.9% |
| Analyst consensus | 100% buy (1) | 36% buy / 55% hold / 9% sell (11) |
| Analyst price target | $31 (+23%) | $198 (+11%) |
| StockVane view | ||
| StockVane Quant Rating | C (87) | C (51) |
| Company | ||
| Employees | 4,571 | 60,500 |
| Founded | 1915 | 1929 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.